chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started feeling very tired at dinner. I realize I couldn't stay for dessert. I beginning to start coughing and had trouble breathing. I went to bed and woke up the next day. I couldn't walk with my group. I went to the pharmacy and got some cough medicine. I stayed in bed and couldn't participate. I did get something to eat but couldn't eat it all. The next day I was able to walk only 7 miles. On Thursday I still had cough and lung issues. On Sunday I went to a hospital and saw a doctor. She listened to my lunges and did not hear any fluid in my lunges. They did not take an x-ray. I was given a prescription for anti-inflammatory. I started feeling better on Monday. I tested positive for COVID-19.
Mild muscle aches; Muscle soreness at site of injection; Received Pfizer BioNTech Covid 19 vaccine booster shot; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 13Dec2021 10:15 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (MANUFACTUERER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 13Dec2021, outcome "unknown", described as "Received Pfizer BioNTech Covid 19 vaccine booster shot"; VACCINATION SITE PAIN (non-serious) with onset 13Dec2021 15:15, outcome "recovering", described as "Muscle soreness at site of injection"; MYALGIA (non-serious) with onset 13Dec2021 21:15, outcome "recovering", described as "Mild muscle aches". Therapeutic measures were taken as a result of vaccination site pain, myalgia.  Additional information: Event took place after use of product. Patient responded to Tylenol & ibuprofen.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Menactra given instead of Prevnar, no adverse reaction, no treatment needed. Child too young for MENACTRA.
This non-valid spontaneous report was received from a nurse and refers to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history were not provided. On unknown dates, the patients were vaccinated with an improperly stored doses of M-M-R II lot #N024698, expiration date 08-SEP-2019 and lot # N023150, expiration date 24-AUG-2019 (dose, site and route of administration not reported) as well as ROTATEQ lot #R002517, expiration date 19-SEP-2019 (dose, site and route of administration not reported), both for prophylaxis. The doses of M-M-R II were reconstituted with properly stored sterile diluent. Administered doses of vaccines experienced the temperature excursion between 47 and 77 degrees Fahrenheit (F) (also reported as 50.9 F) for 46 minutes. The temperature was measured with Digital Data Logger. There were no previous excursions reported. No adverse effects were reported.
Worsening of left knee pain to the point that it was difficult walk, go up and down stairs. Site was inflamed and hot. It's not that I haven't had MILD discomfort in that knee, but it worsened significantly after the booster.
Experiencing bruising, when she bumps herself; Lumps on leg and hand; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Experiencing bruising, when she bumps herself) and MASS (Lumps on leg and hand) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Anxiety (history of anxiety attack years ago), Heart murmur and COVID-19 in October 2020.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced CONTUSION (Experiencing bruising, when she bumps herself) and MASS (Lumps on leg and hand). At the time of the report, CONTUSION (Experiencing bruising, when she bumps herself) and MASS (Lumps on leg and hand) outcome was unknown.            No concomitant medications provided.  No treatment medications provided.   This case was linked to MOD-2021-405008 (Patient Link).
Chills, body aches, headache  for 24 hours?Tylenol taken.  Dizziness for 1 week afterward, ongoing.
Immunization administered 9/14/04. 9/15/04 seen at clinic with complaints of itching, hives like skin lesion over multiple body area. Temp 99 degrees. Treatment: Atarax syrup, oatmeal baths, Topicort Cream
Patient received the Johnson & Johnson COVID vaccine on 4/11/21 and developed dyspnea, fevers, and nonproductive cough about 2 days later. He continued to feel worse over time and presented to urgent care on 4/22/21. He had a chest X-ray done which showed bilateral infiltrates and he was found to be hypoxic, so he was sent to the ED.  Patient was then admitted to the hospital for COVID treatment since he required 4 L O2 in the ED.
Vaccine 9/29/21, no problems until 10/06/21 when what seemed to be a small cold starting with dry cough, clear runny nose, small amount of congestion, by 10/10/21 shortness of breathe started to do breathing treatments, same on 10/11/21 at approx 5:45pm I was completed winded and out of breathe and was taken to Medical Center in respiratory destress. I spend the next 3 days in ICU then transferred to medical floor for the next 5 days. I am home now on oxygen and recovering slowly.  I was also on a Bipap machine and slowly weaned off of that.
Information has been received from a medical assistant concerning an unspecified number of patients of unknown age and gender. Patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On an unknown dates, the patients were vaccinated with doses of improperly stored ROTATEQ (dose and route not reported, lot # L038534 and expiration date 19-AUG-2017). The vaccines were exposed to 46.9F for 1 hour 15 minutes. No previous temperature excursion was reported. No adverse events were reported. This is one of several reported received from the same reporter. Additional information has been requested.
within 1 minute if receiving vaccine while resident was ambulating to observation area she collapsed. ems and nurse on site immediately went to residents aide.
Headache, Sinuses clogged/facial pain, throat, rhinitis, arm soreness Narrative:
A pharmacist reported that a patient received an injection of tetanus toxoid (manufacturer unknown) 15 years ago. The patient subsequently devleoped vomiting, rash and nausea. This event was diagnosed as an allergic reaction. No further information was available at the date of this report.
This spontaneous report was received from a medical assistant and refers to multiple unspecified patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients received doses of improperly stored PROQUAD (Merck) (lot # L025204, expiration date: 07-JAN-2017; lot # reported as M010476, expiration date: 01-SEP-2017; lot # L050909, expiration date: 14-JUN-2017; lot # L031601, expiration date: 18-FEB-2017; lot # reported as L026602, expiration date: 24-SEP-2016; dose and route were not provided). The vaccine underwent temperature excursion of -13 degrees Celsius for 48 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Lethargy, low BP & tachycardia, chest pain. Admitted to hospital 11/22  with Dx. of Pulmonary Embolisms & DVT's in right Peritoneal Veins. Discharged back to facility 11/24.
This spontaneous report as received from a Registered Nurse refers to a unspecified number of patients of unknown gender and unknown age. It was reported that on an unknown date, the unspecified number of patients received unspecified doses of GARDASIL, (dose number, lot/batch number, expiration date, route of administration not reported) that were improperly stored from 20-MAR-2014 to 07-MAY-2014. Nurse stated that vaccines were exposed to 10.5C for 56.05 hours cumulatively through 07-MAY-2014. It was reported that also M-M-R II, PNEUMOVAX, ROTATEQ and PEDVAX were improperly stored (event captured in MARRS# 1405USA012894, 1406USA000956, 1406USA000957 and 1406USA000958 respectively). No adverse effects were reported. This is one of several reports from the same reporter. Follow-up information has been received from the Registered Nurse. It was reported that the nurse was inquiring about temperature excursions that occurred from October 2013 to March 2014. The nurse also stated they were replacing the refrigerator, freezer, and the data logger and were sending the old data logger for calibration to the health department. All telephone attempts to obtain follow up information have been unsuccessful. Follow up information has been received from Registered Nurse on 27-JUN-2014. The nurse stated that one dose of GARDASIL (Lot#J011960, expiration date 06-AUG-2015, dose not reported) that was exposed for 4 hours to highest temperature of 8.5C from 28-AUG-2013 to June 2014 was administered to unspecified patient (unknown age and gender) on an unknown date. This is one of several reports from the same source. Additional information is not expected.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with improperly stored GARDASIL lot # K007264, Exp: 02-MAR-2017; Lot: K010574 Exp: 08-APR-2017, Lot: L007531 Exp: 04-NOV-2016 (dose and route were not reported). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Fever, headache, fatigue, dizziness, left upper arm redness, left upper arm swelling, left upper arm induration, enlarged lymph nodes to left axilla and left collar bone, decreased active ROM left upper extremity.
Post eating blood sugar normally runs 200-220. Today after receiving the 2nd dose, post 2 hour blood sugar ( without taking insulin x24 hrs ) was 340.   I take 30 units of Humalog after eating. And 100 units of Lantus at night.
Very large swelling of injection site, redness and warmth of injection site.  Facial swelling 08/29/15.
Tired; flu-like symptoms; This non-serious case was reported by a consumer and described the occurrence of tiredness in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tiredness (Verbatim: Tired) and influenza-like symptoms (Verbatim: flu-like symptoms). The outcome of the tiredness and influenza-like symptoms were resolving.   The reporter considered the tiredness and influenza-like symptoms to be related to Shingrix.     The company considered the tiredness and influenza-like symptoms to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-JUN-2023 The case was reported for patient's friend. The reporter reported of feeling tired and flu like symptoms after 2nd dose of Shingrix and felt better within 12 hours.
Did not get a complete dose due to the syringe leaking around the hub; Did not get a complete dose due to the syringe leaking around the hub; A spontaneous report received from a nurse concerning a patient, who was participating in the mRNA-1273 Emergency Use Program and the patient not getting the complete dose of vaccine due to the syringe leaking around the hub.    The patient's medical history was not provided. No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 on an unknown date for prophylaxis of COVID-19 infection.   The nurse reported that an employee receiving the Covid-19 vaccine did not get a complete dose due to the syringe leaking around the hub. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The events not getting the complete dose due to the syringe leaking around the hub was considered resolved on the same day.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273. There were no reported AEs associated with this case of incorrect dose administered and syringe issue.
pt recv 3 doses of vax 27DEC84 & serconverted;1991 anti-HBs was positive;MAY94 & MAY95 pt found to be core antibody positive on both occasions;
This study case was received from the investigator on 21 July 2011. A 21-year-old male subject received on 13 April 2011 the following vaccinations: an injection of ACAM2000 (lot number not reported) and Anthrax vaccine (manufacturer and lot number not reported). The subject had a medical history of chest pain, dizziness/fainting spells, shortness of breath, and asthma (including exercise induced). The subject's testing from 17 April 2011 reported an abnormal troponin I of 6.04 and an abnormal electrocardiogram (ECG). His echocardiogram results were not available. On 29 April 2011, the subject was diagnosed with acute pericarditis, unspecified. The outcome was not reported. Additional information will be requested from the investigator. Documents held by sender: None.
Pt recv vax on 10/30/98; on 10/31/98 pt exp sore vax site,{ weak, myalgia} entire body x 3 mon; tx=Alleve
I felt fine directly after. But after 8 hours I started noticing hives on my left arm (same arm that received the injection). It was all over my arm from my shoulder to my wrist. The next day I woke up with a weak and achy body and I developed chills and a headache around 3pm.  They only lasted that night. I did not take any medication for any of the symptoms. However, the hives lasted 2 more days.
High fever (102 degrees), body aching 3 days after administration. 7/5/12 pt feeling about 50% better.
Cant hear very well/hears a muffled voice/ unless the person is standing next to her, cant make out what others are saying/ can feel the vibrations of the noise; dizzy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Cant hear very well/hears a muffled voice/ unless the person is standing next to her, cant make out what others are saying/ can feel the vibrations of the noise), DIZZINESS (dizzy) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (Cant hear very well/hears a muffled voice/ unless the person is standing next to her, cant make out what others are saying/ can feel the vibrations of the noise), DIZZINESS (dizzy) and HEADACHE (Headache). At the time of the report, HYPOACUSIS (Cant hear very well/hears a muffled voice/ unless the person is standing next to her, cant make out what others are saying/ can feel the vibrations of the noise), DIZZINESS (dizzy) and HEADACHE (Headache) outcome was unknown.            No concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
14may90 pt vax heptaB. 21may90 pt ex vertigo and worsening of tinnitus. ct scan of head was normal
TINY BLOOD SPOTS SIZE OF A UNSHARPENED PENCIL ON BREAST, ARM, STOMACH AND LEG; CHILLS; WEAKNESS; This spontaneous report received from a patient concerned a 74 year old female. The patient's weight was 108 pounds, and height was 62 inches. The patient's concurrent conditions included: thrombocythemia (high platelets), easy bruising, vegan, non-alcohol user, and non-smoker, and other pre-existing medical conditions included: Patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with epinephrine for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the patient experienced chills. On 30-MAR-2021, the patient experienced weakness. On JUL-2021, the patient experienced tiny blood spots size of a unsharpened pencil on breast, arm, stomach and leg. Laboratory data (dates unspecified) included: Platelet count (NR: not provided) High. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiny blood spots size of a unsharpened pencil on breast, arm, stomach and leg, and chills, and weakness on 02-APR-2021. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Information has been received from a registered nurse referring to unspecified numbers of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On an unspecified day, these patients were vaccinated with improperly stored RECOMBIVAX HB (lot # J014855, expiration date: 16-APR-2016; lot# K016005, expiration date: 27-AUG-2016; lot# K026666, expiration date: 22-OCT-2018; lot# L004754, expiration date: 11-OCT-2016; strength, dose and route unknown). There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Right after the 3-4 day nausea and sore arm side effects right after the forst dose, I Started getting unusual extreme head pain. Pain was so bad I could not function. I was not formerly Diagnosed with "Giant Cell Arteritis" until shortly after the Biopsy removing arteries from my head on May 5th, 2021. The Rheumatolist immediately put me on 60 Mg's of steroids and Actemra which is the only medication to combat GCA. Since Jan 27th 2021, my life has seemed to change forever as I am still trying to recover from this serious disease caused by the spike proteins to my head that I have never experianced before nor has any family member, direct or indirect. I was healthy and athletic before Jan 27 2021. Now, I CANNOT FUNCTION doing my job on my computer working with clients. I still have headaches almost daily, swollen feet, ankles and legs. Severe artheritis and pain in left side joints, Shoulder, Bicep, Elbow and forearm. Fingers go numb at night as well as toes. Extreme Leg cramps late at night, Extreme weight gain to 320 lbs from 260 lbs. in just 2.5 months. Broken blood vessells in both arms, Toes turned dark blue on left foot. Head aches and head pain still exist off and on in waves with no normal schedule. complete lack of energy all the time and when I try to push it I get fatiged quickly and have to rest or lie down. Altitudes about 4,000 ft. seem to really get me exhausted if extering any energy.. Also have stomach and upper resperatory pain. My esophagus at one point seemed to block my air passage resulting in a trip by ambulance to emergency as was have trouble breathing. There is much more to the list of effects like brain fog, memory issues etc. etc.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's wife. The age at vaccination was not reported. A year after receiving Shingles vaccine, the patient got shingles, past winter from the date of reporting. The wife reported that, might be was milder case but he definitely got them. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation of shingles were not provided.
Swelling of facial tissue  on right side lower jaw..started morning after injection and still present??have started Benadryl
Patient have vaccinated twice. One on 9/30/15 with flu quadrivalent at her doctor's office and one on 10/26/15 with Fluzone high-dose at her pharmacy.  No symptom is reported.
Injection site bruised and surrounding area covering 6 to 8 inches red, mottled rash (painful). Still clearly present 2 weeks post-injection.
This spontaneous report as received from a nurse refers to a 9 months 11 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
sleepy; Tired; Maternal exposure during breastfeeding; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (sleepy), FATIGUE (Tired) and MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breastfeeding) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: J&J. Past adverse reactions to the above products included No adverse event with J&J.    On 16-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Dec-2021, the patient experienced SOMNOLENCE (sleepy), FATIGUE (Tired) and MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breastfeeding). On 16-Dec-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breastfeeding) had resolved. At the time of the report, SOMNOLENCE (sleepy) and FATIGUE (Tired) outcome was unknown.            No Concomitant medication was reported.  It was reported that patient had second booster dose from Pfizer on 27-May-2022.  No treatment medication was reported.   This case was linked to MOD-2022-592987 (Parent-Child Link).   See case MOD-2022-592987 for details regarding the child case.
I had a hard time breathing, coughing and had a fever. I felt like I had a cold or flu that did not get better after a week. I had a hard time keeping food down and I did vomit at times. My fever was about 100 to 101 at times. I called my doctor and he prescription me medicine that did not help. So, I call my doctor again and he told me to go to urgent care. They did a COVID-19 test and a x-ray, which came back negative and normal. They said I had a virial infection.